VitaNova Life Sciences Corp (VNOV) › Operating Cash FlowVitaNova Life Sciences Corp (VNOV) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2017: -$6.5K2018: -$9.3K2019: -$49.1K2020: -$53.6K2021: -$42.3K2022: $4.1K2023: -$18.4K2024: -$375.9K2025: $192.8K$192.8K2017Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$192.8K+151.3%2024-$375.9K-1945.6%2023-$18.4K-552.5%2022$4.1K+109.6%2021-$42.3K+21.1%2020-$53.6K-9.1%2019-$49.1K-428.4%2018-$9.3K-43.1%2017-$6.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share